Table 4.
Age-specific prevalence of metabolic syndrome in middle-aged population, Shahroud, Iran, 2014
| Age groups by sex | IDF Proportion (95% CI) | P* | ATP III Proportion (95% CI) | P | AACE Proportion (95% CI) | P* |
|---|---|---|---|---|---|---|
| Male | ||||||
| 45-49 | 49.65 (43.82-55.48) | 0.858 | 41.99 (36.04-47.95) | 0.268 | 48.07 (41.97-54.17) | 0.606 |
| 50-54 | 51.19 (46.89-55.50) | 44.18 (40.02-48.33) | 47.62 (43.52-51.72) | |||
| 55-59 | 50.40 (46.11-54.86) | 43.20 (38.89-47.51) | 45.24 (41.02-49.45) | |||
| 60-64 | 53.57 (48.53-58.61) | 49.61 (44.65-54.58) | 45.54 (40.72-50.38) | |||
| 65-69 | 50.62 (44.07-57.16) | 45.64 (38.78-52.50) | 42.04 (35.36-48.72) | |||
| Total | 51.17 (48.88-53.46) | 44.89 (42.60-47.18) | 45.93 (43.75-48.12) | |||
| Female | ||||||
| 45-49 | 54.65 (50.85-58.46) | <0.001 | 53.28 (49.46-57.09) | <0.001 | 49.74 (45.74-53.75) | <0.001 |
| 50-54 | 65.75 (62.65-68.85) | 63.73 (60.49-66.97) | 57.61 (54.39-60.83) | |||
| 55-59 | 68.67 (64.96-72.37) | 67.77 (64.12-71.41) | 63.17 (59.36-66.99) | |||
| 60-64 | 71.27 (67.06-75.49) | 69.76 (65.56-73.97) | 62.93 (58.44-67.42) | |||
| 65-69 | 76.87 (71.90-81.83) | 74.73 (69.66-79.80) | 67.73 (62.15-73.31) | |||
| Total | 66.18 (64.45-67.91) | 64.64 (62.88-66.41) | 59.23 (57.40-61.06) | |||
| Total population | ||||||
| 45-49 | 53.01 (44.94-56.08) | <0.001 | 49.59 (46.41-52.77) | <0.001 | 49.19 (45.79-52.59) | 0.040 |
| 50-54 | 59.97 (57.40-62.53) | 56.00 (53.36-58.64) | 53.63 (51.11-56.16) | |||
| 55-59 | 60.82 (57.90-63.75) | 57.24 (54.28-60.20) | 55.46 (52.51-58.41) | |||
| 60-64 | 63.16 (59.67-66.65) | 60.56 (57.15-63.97) | 54.96 (51.41-58.51) | |||
| 65-69 | 64.69 (60.42-68.97) | 61.30 (56.98-65.63) | 55.79 (51.32-60.25) | |||
| Total | 60.00 (58.53-61.49) | 56.55 (55.07-58.04) | 53.75 (52.31-55.20) |
*Pearson χ2. CI=Confidence interval; ATP III=Adult Treatment Panel III; IDF=International Diabetes Federation; AACE=American Association of Clinical Endocrinologists